Numeral (JSE:XII) EBIT: R8.27 Mil (TTM As of Nov. 2025)


JSE:XII Numeral Ltd JSE:XII
10 GF Score
Price R0.33
! 5 Warning Signs
View Full Analysis

What is Numeral EBIT?

Numeral JSE:XII 10 EBIT is R8.27 Mil as of Nov. 2025. GuruFocus rates JSE:XII with a GF Score™ of 10/100. The stock has 5 warning signs investors should review.

Numeral's earnings before interest and taxes (EBIT) for the three months ended in Nov. 2025 was R-9.67 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Nov. 2025 was R8.27 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Numeral's annualized ROC % for the quarter that ended in Nov. 2025 was -71.34%. Numeral's annualized ROC (Joel Greenblatt) % for the quarter that ended in Nov. 2025 was -242.96%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Numeral's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Nov. 2025 was 3.30%.

Numeral  (JSE:XII) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Numeral's annualized ROC % for the quarter that ended in Nov. 2025 is calculated as:

ROC % (Q: Nov. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Aug. 2025 ) + Invested Capital (Q: Nov. 2025 ))/ count )
=-38.664 * ( 1 - 6.73% )/( (48.239 + 52.861)/ 2 )
=-36.0619128/50.55
=-71.34 %

where

Invested Capital(Q: Aug. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=61.422 - 10.653 - ( 2.53 - max(0, 11.431 - 28.614+2.53))
=48.239

Invested Capital(Q: Nov. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=61.631 - 6.582 - ( 2.188 - max(0, 7.323 - 26.792+2.188))
=52.861

Note: The Operating Income data used here is four times the quarterly (Nov. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Numeral's annualized ROC (Joel Greenblatt) % for the quarter that ended in Nov. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Nov. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Aug. 2025  Q: Nov. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-38.664/( ( (2.354 + max(12.193, 0)) + (2.429 + max(14.852, 0)) )/ 2 )
=-38.664/( ( 14.547 + 17.281 )/ 2 )
=-38.664/15.914
=-242.96 %

where Working Capital is:

Working Capital(Q: Aug. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(22.668 + 0.956 + 0) - (10.653 + 0 + 0.778)
=12.193

Working Capital(Q: Nov. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(20.745 + 1.413 + 0.017000000000003) - (6.582 + 0 + 0.741)
=14.852

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Nov. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Numeral's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Nov. 2025 )
=8.269/250.362
=3.30 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Numeral EBIT Related Terms

Numeral EBIT Historical Data

* Premium members only.

The historical data trend for Numeral's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Numeral EBIT Chart

Numeral Annual Data
Trend Dec14 Dec15 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.86 -0.96 -1.63 0.40 8.72

Numeral Quarterly Data
Aug20 Nov20 Feb21 Aug21 Nov21 Feb22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.11 2.22 7.70 8.02 -9.67

JSE:XII vs ZTS, UTHR, VTRS: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Numeral's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Numeral EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Numeral's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Numeral's EV-to-EBIT falls into.


JSE:XII
10GF Score
Numeral Ltd JSE:XII
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Numeral EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Nov. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was R8.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of R8.27 Mil mean?
Numeral (JSE:XII) has a EBIT of R8.27 Mil as of Nov. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Numeral.
Is Numeral's EBIT too high?
Numeral's current EBIT is R8.27 Mil. Overall, Numeral has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Numeral's EBIT compare to ZTS and UTHR?
Numeral's EBIT of R8.27 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Numeral. Numeral's current EBIT is R8.27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Numeral stock overvalued right now?
Numeral (JSE:XII) has a current EBIT of R8.27 Mil. The current EBIT is R8.27 Mil. Numeral's overall GF Score™ is 10/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Numeral (JSE:XII), the current EBIT is R8.27 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Numeral Business Description

Other Exchanges NXII.N0000:Mauritius
Address Sayed Hossen Road, Unit 13 Socota Phoenicia, Phoenix, MUS
Numeral Ltd is an investment holding company based in Mauritius with a focus on fintech, biotechnology, and asset management. Geographically it has a presence in countries across Africa, Europe and Asia. The majority of its revenue is generated in the form of Trading income.
10GF Score

Get the complete analysis for JSE:XII

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R0.33
Price